companydata.dkcompanydata.dk

Pivotal Clinical ApS: Financial statements 2024

CVR: 40343040

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Pivotal Clinical ApS (CVR 40343040) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -25 and a net result of DKK -32 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 49,968. The solvency ratio was 100%.

Equity
DKK 49,968
Total Assets
DKK 49,968
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--25-3250K0
2023--050K0
2022--36650K-
2021---36650K-
2020--050K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Pivotal Clinical ApS: The 2023 annual report is outMar 13, 2024

Pivotal Clinical ApS has published its annual report for 2023. The net result was DKK 0.

About Pivotal Clinical ApS

Pivotal Clinical ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ibrahim Naman Farr Juri. The company is owned by Pivotal S.L.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -75 and a net result of DKK -82 compared with DKK -32 the year before. Equity in the 2025 report amounted to DKK 49,886.

Source: annual report 2025, Danish Business Authority

Other financial years